查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197438

碎石机市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Lithotripsy Device Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2021 年全球碎石设备市场价值 16.7 亿美元，预计到 2027 年将达到 20.3 亿美元，在 2022-2027 年的预测期内以 5.5% 的复合年增长率增长。

这个市场主要是由技术进步、尿路结石发病率增加、体外衝击波碎石术发病率增加以及意识提高推动的。 COVID-19 的爆发严重影响了碎石术市场。 麻醉师需要管理感染 COVID-19 的患者，这迫使他们放弃择期手术。 择期手术不得不取消，因为需要一名麻醉师来管理感染 COVID-19 的患者。 我们不得不减少用于泌尿科患者的床位数量，以便为我们新的 COVID-19 病房腾出专用床位和工作人员。 我们还需要确保医院污染不会感染择期手术患者。 最重要的是，从泌尿科的角度来看，大部分剩余的泌尿科医务人员现在都完全致力于管理新 COVID-19 病房中的感染患者。 因此，不断增长的 COVID-19 患者群体和择期手术的减少对 2020 年的市场产生了影响。

尿石症是一种常见的泌尿系统疾病，给全世界的医疗保健系统带来了沉重的负担。 这与终末期肾病风险增加有关，推动了对碎石设备的需求。 根据欧洲泌尿外科协会的数据，2019 年尿路结石的患病率从 1% 到 20% 不等。 生活水平高的国家，如加拿大、瑞典和美国，肾结石的患病率明显更高（>10%）。 在过去的二十年里，一些地区报告说增长了 37% 或更多。 肾结石与终末期肾病的风险有关。 随着世界范围内尿石症的增加，需要一种安全、有效且廉价的尿石症治疗方法。

多年来，碎石术一直是治疗肾结石的首选方法。 其主要原因是其相对安全、成本低、恢復时间短和患者预后良好。 因此，所有这些因素都在推动市场的增长。

然而，除了一些好处外，碎石疗法也存在一些风险。 这种治疗有时会导致内出血，可能需要输血。 副作用是肾臟受损，因为小结石颗粒会阻塞尿液。 还有高血压等并发症，也在製约市场。 此外，碎石冲击波的副作用往往会导致高血压、糖尿病，在某些情况下还会导致肾功能永久丧失，这对碎石市场构成了重大障碍。

碎石机市场趋势

体外衝击波碎石机 (ESWL) 细分市场预计将占据较大的市场份额

体外衝击波碎石术是一种治疗肾结石和输尿管结石的非手术方法。 一股高能衝击波穿过身体，将石头打碎成沙粒般的细小颗粒。 体外衝击波碎石术 (ESWL) 用于治疗肾结石和输尿管结石。 该技术正在被世界各地的医生使用，预计在未来几年将变得更加流行，因为它具有微创、减轻疼痛、缩短住院时间和加快恢復时间等优势。

随着 COVID-19 病例的增加，泌尿外科手术的数量正在减少，体外衝击波碎石机 (ESWL) 的数量也在这段时间减少，这将对市场产生轻微的负面影响。

这是最常见的体外碎石术。 在体外衝击波碎石术 (ESWL) 中，一种称为溶菌碎石机的特殊机器会产生高能衝击波，例如声波、X 射线或超声波，这些衝击波穿过身体直至击中肾结石。

ESWL 最早在美国实施。 然而，据报导一些患者在 ESWL 治疗后不成功。 ESWL 仅用于某些肾结石和输尿管结石。 因此，它并不适用于所有石材类型和场地。 该过程通常被认为是安全和快速的，因为它只需要 45 分钟。 对非侵入性程序不断增长的需求导致了 ESWL 的采用。

因此，再加上肾臟相关疾病的增加和全球意识的提高，很可能会在预测期内推动市场增长。

北美在碎石机市场份额最大

在北美，碎石术市场预计将在预测期内增长。 据估计，慢性肾病在女性中比在男性中更常见。 众所周知，全世界患有慢性肾病的患者人数正在增加。 美国肾病统计数据传达了慢性肾病 (CKD) 和终末期肾病 (ESRD) 的负担。

COVID-19 大流行对碎石市场产生了负面影响，因为手术数量减少导致碎石设备的使用减少。 大流行还扰乱了供应炼和市场，对企业和金融市场产生了负面影响，从而直接影响了生产和需求。

根据美国疾病控制和预防中心的数据，2019 年，估计约有 3700 万人（即成年人口的七分之一，即 15%）将患有慢性肾病。 随着肾病病例的增加，美国每年完成超过 50,000 例碎石手术，推动了碎石市场的发展。

2019 年 1 月，Shockwave Medical 开始了一项冠状动脉碎石术设备的关键美国临床试验，该设备旨在为严重钙化的冠状动脉病变准备支架置入术。 该技术利用声波压力波在不损伤动脉组织的情况下打碎内膜和内侧钙，预计将扩大公司业务并帮助推动该国的碎石机市场。

因此，由于美国肾结石病的高患病率和高治疗率，该地区在全球市场的份额预计在预测期内将显着增长。 此外，产品发布、收购、联合研究等预计将推动该地区的市场。

碎石设备市场竞争者分析

碎石术市场是一个竞争激烈的市场。 碎石设备的主要市场参与者包括 EDAP TMS、波士顿科学公司、奥林巴斯公司、Accuron、DirexGroup 等。 每家公司都采取了某些战略举措，例如合併、新产品发布、收购和合作伙伴关係，以帮助巩固其市场地位。 此外，公司还专注于增加碎石设备的应用，以巩固其在预测期内的地位。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 增加尿石症的负担
    • 增加体外衝击波碎石术的数量
    • 微创手术的技术进步
  • 市场製约因素
    • 与碎石术相关的副作用
    • 去除结石的替代疗法的可用性
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模:百万美元）

  • 按类型
    • 体外衝击波碎石装置
    • 体石破碎机
      • 激光碎石设备
      • 电液碎石机
      • 超声波碎石机
      • 气动（弹道）碎石机
  • 通过申请
    • 肾结石
    • 输尿管结石
    • 胰腺结石
    • 胆管结石
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • EDAP TMS
    • Electro Medical Systems SA（Boston Scientific Corporation）
    • Olympus Americas
    • Dornier MedTech
    • Becton, Dickinson, and Company
    • Storz Medical AG
    • Cook Medical LLC
    • Walz Elektronik GmbH
    • Novamedtek
    • Elmed Medical Systems
    • Karl Storz SE & Co. KG
    • Siemens Healthineers AG
    • Richard Wolf GmbH
    • DirexGroup
    • Lumenis

第7章 市场机会与今后动向

简介目录
Product Code: 64420

The global lithotripsy device market was valued at USD 1.67 billion in 2021, and it is expected to reach USD 2.03 billion by 2027, registering a CAGR of 5.5% during the forecast period 2022-2027.

The market is primarily driven by the increasing incidence of urolithiasis, a rise in the number of extracorporeal shock waves lithotripsy procedures, and technological advancements coupled with rising awareness. The COVID-19 pandemic has severely impacted the lithotripsy devices market, as anesthesiologists were needed to manage patients infected with COVID-19 and, therefore, had to withdraw from elective surgery. The number of beds used for urological patients had to be reduced to provide dedicated beds and personnel for the new COVID-19 wards. Also, there was a need to not infect elective patients via hospital contamination. Most importantly, from a urological perspective, most of the residual urological medical staff became entirely dedicated to managing the infected patients on the newly formed COVID-19 ward. Hence, the growing COVID-19 patient pool and lesser number of elective surgeries impacted the market in 2020.

Urolithiasis is a common urologic problem, and it poses a significant burden on the healthcare system globally. It is associated with an increased risk of end-stage renal failure, which is driving the demand for lithotripsy devices. As per the European Association of Urology, in 2019, the prevalence rates for urinary stones varied from 1% to 20%. In countries with a high standard of life, such as Canada, Sweden, or the US, renal stone prevalence is notably high (> 10%). For some areas, an increase of more than 37% has been reported over the last 20 years. It has been associated with an increased risk of end-stage renal failure. Thus, the increasing global prevalence of urolithiasis necessitates safe, efficacious, and affordable treatment for urolithiasis.

Over the years, lithotripsy has become the most preferred method for the treatment of kidney stones, mainly due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes. Thus, all these factors are responsible for driving the market's growth.

However, apart from the several advantages, there are several risks associated with the lithotripsy treatment. This treatment sometimes leads to internal bleeding and may need a blood transfusion. It can lead to adverse side effects, where the kidney may get damaged due to blockage in the urine flow passage caused by tiny stone particles. There are complications, such as high blood pressure, which also restrain the market. Also, the adverse effects of lithotripsy shock waves often result in hypertension, diabetes, and, in some cases, permanent loss of functional renal volume, which act as major barriers for the lithotripsy devices market.

Lithotripsy Device Market Trends

Extracorporeal Shock Wave Lithotripsy (ESWL) Devices Segment Expected to Have a Significant Market Share

Extracorporeal shock wave lithotripsy is a technique for treating stones in the kidney and ureter that does not require surgery. Instead, high-energy shock waves are passed through the body and used to break stones into pieces as small as grains of sand. The extracorporeal shock wave lithotripsy devices (ESWL) are used for the treatment of kidney and ureter stones. This technology has been utilized by physicians worldwide and is expected to increase its penetration over the coming years due to the advantages offered, such as minimal invasiveness, reduced pain, shorter hospital stay, and quicker recovery time.

With the growing cases of COVID-19, fewer urology surgeries are being performed, which has also reduced the number of extracorporeal shock wave lithotripsy (ESWL) devices during this time, which is anticipated to have a slight negative impact on the market.

It is the most common lithotripsy performed outside the body. During extracorporeal shock wave lithotripsy (ESWL), a special machine known as lithotripter generates high-energy shock waves such as sound waves, x-rays, or ultrasound, which pass through the body until they hit the kidney stones.

ESWL was first performed in the US. However, it has been reported that some patients may not experience a successful outcome following ESWL. ESWL is only used in selected stones in the kidney and ureter. Therefore, it does not apply to all stone types or locations. Generally, this procedure is considered safe and less time-consuming as it takes only 45 minutes to perform. The growing demand for non-invasive procedures is leading to the adoption of ESWL.

Hence, the increasing number of kidney-related disorders, coupled with rising awareness across the globe, are likely to augment the market growth over the forecast period.

North America Holds the Largest Share of the Lithotripsy Device Market

In North America, the lithotripsy devices market is projected to witness growth over the forecast period. Chronic kidney diseases are estimated to be more common in women than men. The number of chronic kidney diseases is found to be increasing globally. Kidney disease statistics for the US convey the burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The COVID-19 pandemic has had a negative impact on the lithotripsy devices market due to the reduced number of surgeries being performed, resulting in reduced usage of the devices. The pandemic also affected the market by directly affecting production and demand by creating supply chain and market disruptions and financially impacting firms and financial markets negatively.

According to the Centers for Disease Control and Prevention, in 2019, around 37 million people, i.e., 1 out of every 7, or 15% of the adult population, were estimated to have chronic kidney diseases. With the increasing cases of kidney diseases, over 50,000 lithotripsy procedures are completed annually in the US, which helps in driving the lithotripsy devices market.

In January 2019, Shockwave Medical launched a US pivotal trial for its coronary lithotripsy device, designed to prepare heavily calcified coronary lesions for stenting. This technology uses sonic pressure waves to fracture intimal and medial calcium without damaging arterial tissue, which is likely to expand the company's business and help in driving the lithotripsy devices market in the country.

Hence, during the forecast period, the region's share of the global market is likely to grow significantly, owing to the high prevalence and the treatments of kidney stone disease in the US. Also, product launches, acquisitions, and collaborations are expected to promote the regional market.

Lithotripsy Device Market Competitor Analysis

The lithotripsy device market is competitive. The key market players operating in lithotripsy devices are EDAP TMS, Boston Scientific Corporation, Olympus Corporation, Accuron, and DirexGroup, among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Furthermore, companies are also focusing on increasing the applications of lithotripsy devices to strengthen their positions over the forecast period.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Urolithiasis
    • 4.2.2 Rise in Number of Extracorporeal Shock Wave Lithotripsy Procedures
    • 4.2.3 Technological Advancements in Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Adverse Effects Associated with Lithotripsy
    • 4.3.2 Availability of Alternative Treatments for Stone Removal
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Extracorporeal Shock Wave Lithotripsy Devices
    • 5.1.2 Intracorporeal Lithotripsy Devices
      • 5.1.2.1 Laser Lithotripsy Devices
      • 5.1.2.2 Electrohydraulic Lithotripsy Devices
      • 5.1.2.3 Ultrasonic Lithotripsy Devices
      • 5.1.2.4 Pneumatic (Ballistic) Lithotripsy Devices
  • 5.2 By Application
    • 5.2.1 Kidney Stones
    • 5.2.2 Ureteral Stones
    • 5.2.3 Pancreatic Stones
    • 5.2.4 Bile Duct Stones
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 EDAP TMS
    • 6.1.2 Electro Medical Systems SA (Boston Scientific Corporation)
    • 6.1.3 Olympus Americas
    • 6.1.4 Dornier MedTech
    • 6.1.5 Becton, Dickinson, and Company
    • 6.1.6 Storz Medical AG
    • 6.1.7 Cook Medical LLC
    • 6.1.8 Walz Elektronik GmbH
    • 6.1.9 Novamedtek
    • 6.1.10 Elmed Medical Systems
    • 6.1.11 Karl Storz SE & Co. KG
    • 6.1.12 Siemens Healthineers AG
    • 6.1.13 Richard Wolf GmbH
    • 6.1.14 DirexGroup
    • 6.1.15 Lumenis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS